GLP-1 drugs strengthen those natural stop signals
About this article Cite this article Ussher, J.R., Drucker, D.J
Herbal compounds, based on their components can stimulate GLP-1 secretion and provide glycemic control effects in T2DM in different ways
In this context, murine studies have shown that sweet taste receptors (TAS1R2 and TAS1R3) are predominantly expressed in the hypothalamus and brainstem, whereas bitter receptors (TAS2R116, TAS2R118, TAS2R138, TAS2R104) are mainly expressed in the arcuate nucleus, ventromedial hypothalamus, dorsomedial hypothalamus, and nucleus of the solitary tract (120, 121)
Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation
Efficacy and tolerability of tirzepatide, a dual glucosedependent insulinotropic peptide and glucagonlike peptide1 receptor agonist in patients with type 2 diabetes: a 12week, randomized, doubleblind, placebocontrolled study to evaluate different doseescalation regimens